Tag: Nasal high flow therapy
F&P sees increased demand due to COVID-19 surges
January 22, 2021HME News Staff
Coronavirus, Financial Results, Fisher & Paykel Healthcare, Nasal high flow therapy, Obstructive Sleep Apnea (OSA), Pandemic, Sleep Therapy
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back OfficeTwo face sentencing in test strip fraud
ResMed studies show efficacy of PAP therapy
HealthWell launches COPD assistance fund
Float follows ‘North Star’ to growth
In brief: Numotion incident, EnsoData & Aeroflow partnership, Golden contract
Dexcom releases study, launches new CGM
Rehab Medical honored for ‘commitment’ to employees